Sort by:

select Language:

Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children

World Health Organization (WHO), (2018)

March 2018.Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

Framework for a national plan for monitoring and management of insecticide resistance in malaria vectors

World Health Organization (WHO), (2017)

Effective malaria prevention is threatened by widespread and increasing vector insecticide resistance. Failure to mitigate this threat will likely result in an increased burden of disease, with significant cost implications. This new framework provides support for the development of a national insecticide resistance monitoring and management plan as part of a national malaria strategic plan.

Status report on artemisinin and ACT resistance, April 2017

World Health Organization (WHO), (2017)

The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.

Recognizing neglected tropical diseases through changes on the skin: a training guide for front-line health workers

World Health Organization (WHO), (2018)

The skin of a patient is the first and most visible structure of the body that any health-care worker encounters during the course of an examination. To the patient, it is also highly visible, and any disease that affects it is noticeable and will have an impact on personal and social well-being. The skin is therefore an important entry point for both diagnosis and management. Many diseases of humans are associated with changes to the skin, ranging from symptoms such as itching to changes in colour, feel and appearance. This training guide explains how to identify the signs and symptoms of neglected tropical diseases of the skin through their visible characteristics. It also contains information on how to diagnose and manage common skin problems that front-line health workers may encounter.

Generic risk assessment model for insecticide-treated nets, 2nd ed.

World Health Organization (WHO), (2018)

Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure to insecticides of individuals sleeping under LNs and during the washing of nets.
In an Annex, exposures and health risks are described for the conventional treatment or retreatment of nets (ITNs) with an insecticide considering that such practices may still be used in evaluation of ITNs and their use. The generic model does not include the risks associated with the manufacturing of LNs in a factory environment.

331 hits